Balance Sheet Grifols, S.A.

Stocks

GRF

ES0171996087

Pharmaceuticals

Market Closed - BME Other stock markets 19:37:35 11/06/2026 +04			5-day change	1st Jan Change
8.828 ^EUR	-1.27%		-1.58%	-17.50%

06-09	European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading	MT
06-08	European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading	MT

6a2d4f.hRPkfQQ812J9MLHTpvmTmDJq8Slc_aBw-oV1z2-r1DY.9SW3JWBP4jU5BNOG34DdyksrhBtvjegylbYe_l7Shky8JqwyMXTnVhwE5A

Published financial data: GRIFOLS, S.A.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	4.93B	6.06B	6.59B	7.21B	7.52B
Total Revenues	4.93B	6.06B	6.59B	7.21B	7.52B
Cost of Goods Sold, Total	2.97B	3.83B	4.1B	4.36B	4.6B
Gross Profit	1.96B	2.23B	2.49B	2.85B	2.92B
Selling General & Admin Expenses, Total	1.06B	1.19B	1.37B	1.17B	1.15B
R&D Expenses	355M	361M	395M	363M	380M
Other Operating Expenses	-16.3M	-14.68M	-3.04M	-	-1M
Other Operating Expenses, Total	1.4B	1.54B	1.76B	1.53B	1.52B
Operating Income	563M	695M	736M	1.32B	1.4B
Interest Expense, Total	-234M	-363M	-443M	-602M	-576M
Interest And Investment Income	11.55M	33.86M	62.33M	46.48M	36M
Net Interest Expenses	-222M	-329M	-380M	-556M	-540M
Income (Loss) On Equity Invest.	65.74M	102M	62.82M	36.8M	-8M
Currency Exchange Gains (Loss)	-11.6M	7.72M	-16.39M	-59.76M	-55M
Other Non Operating Income (Expenses)	-43.94M	-122M	-153M	-132M	-33M
EBT, Excl. Unusual Items	350M	354M	249M	608M	759M
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	7.56M	-24.99M	-	-
Asset Writedown	-	-	-	-	-
Other Unusual Items	-	-	-	-164M	-144M
EBT, Incl. Unusual Items	350M	361M	224M	444M	615M
Income Tax Expense	85.13M	90.11M	43.35M	231M	115M
Earnings From Continuing Operations	265M	271M	181M	213M	500M
Net Income to Company	265M	271M	181M	213M	500M
Minority Interest	-82.52M	-62.87M	-121M	-55.89M	-98M
Net Income - (IS)	183M	208M	59.32M	157M	402M
Net Income to Common Incl Extra Items	183M	208M	59.32M	157M	402M
Net Income to Common Excl. Extra Items	183M	208M	59.32M	157M	402M
Per Share Items
Net EPS - Basic	0.27	0.31	0.09	0.23	0.59
Basic EPS - Continuing Operations	0.27	0.31	0.09	0.23	0.59
Basic Weighted Average Shares Outstanding	682M	680M	680M	680M	681M
Net EPS - Diluted	0.27	0.31	0.09	0.23	0.59
Diluted EPS - Continuing Operations	0.27	0.31	0.09	0.23	0.59
Diluted Weighted Average Shares Outstanding	682M	680M	680M	680M	682M
Normalized Basic EPS	0.2	0.23	0.05	0.48	0.55
Normalized Diluted EPS	0.2	0.23	0.05	0.48	0.55
Dividend Per Share	-	-	-	-	-
Payout Ratio	141.65	0.28	-	0.61	31.84
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	785M	963M	1.03B	1.61B	1.7B
EBITA	613M	760M	816M	1.39B	1.46B
EBIT	563M	695M	736M	1.32B	1.4B
EBITDAR	818M	1B	1.08B	1.66B	1.74B
Effective Tax Rate - (Ratio)	24.29	24.94	19.35	52.07	18.7
Total Current Taxes	67.37M	105M	183M	306M	277M
Total Deferred Taxes	17.75M	-15.14M	-140M	-75.07M	-162M
Normalized Net Income	137M	158M	34.28M	324M	377M
Interest Capitalized	18.64M	25.18M	36.89M	27.77M	22M
Interest on Long-Term Debt	252M	388M	479M	561M	534M
Non-Cash Pension Expense	-	766K	3.44M	3.09M	3M
Supplemental Operating Expense Items
Advertising Expense	71.28M	90.65M	78.85M	83.9M	81M
Research And Development Expense From Footnotes	355M	361M	395M	384M	426M
Net Rental Expense, Total	32.94M	38.99M	43.04M	47.12M	45M
Imputed Operating Lease Interest Expense	8.19M	11.57M	15.43M	22.38M	21.73M
Imputed Operating Lease Depreciation	24.76M	27.43M	27.61M	24.74M	23.27M
Maintenance & Repair Expenses, Total	150M	219M	231M	270M	307M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	655M	548M	530M	980M	825M
Short Term Investments	2.03B	30.99M	116M	24.18M	24M
Trading Asset Securities, Total	3.24M	-	-	-	-
Total Cash And Short Term Investments	2.69B	579M	646M	1B	849M
Accounts Receivable, Total	434M	644M	693M	741M	734M
Other Receivables	61.3M	111M	118M	125M	111M
Notes Receivable	39K	48K	120K	213M	12M
Total Receivables	495M	755M	811M	1.08B	857M
Inventory	2.26B	3.2B	3.46B	3.56B	3.3B
Other Current Assets, Total	70.29M	118M	1.54B	84.17M	72M
Total Current Assets	5.51B	4.65B	6.45B	5.73B	5.07B
Gross Property Plant And Equipment	5.11B	6.24B	6.46B	6.94B	6.71B
Accumulated Depreciation	-1.77B	-2.07B	-2.27B	-2.63B	-2.66B
Net Property Plant And Equipment	3.34B	4.17B	4.19B	4.31B	4.05B
Long-term Investments	2.27B	2.44B	565M	529M	460M
Goodwill	6.23B	7.01B	6.8B	7.4B	6.83B
Other Intangibles, Total	1B	1.33B	1.21B	1.19B	1.01B
Accounts Receivable Long-Term	-	-	-	59K	-
Loans Receivable Long-Term	89.1M	96.54M	137M	19.92M	133M
Deferred Tax Assets Long-Term	153M	175M	305M	342M	416M
Deferred Charges Long-Term	633M	1.62B	1.62B	1.74B	1.72B
Other Long-Term Assets, Total	7.76M	36.31M	155M	148M	16M
Total Assets	19.23B	21.53B	21.44B	21.41B	19.71B
Liabilities
Accounts Payable, Total	629M	732M	813M	852M	841M
Accrued Expenses, Total	328M	314M	371M	451M	482M
Current Portion of Long-Term Debt	2.35B	693M	906M	560M	439M
Current Portion of Leases	48.57M	102M	107M	117M	113M
Current Income Taxes Payable	4.52M	15.69M	14.52M	60.54M	25M
Unearned Revenue Current, Total	32.97M	27.64M	28.87M	36.5M	27M
Other Current Liabilities	85.36M	71.33M	74.59M	79.89M	92M
Total Current Liabilities	3.47B	1.96B	2.32B	2.16B	2.02B
Long-Term Debt	6.11B	9.04B	8.63B	8.47B	8.12B
Long-Term Leases	825M	915M	1B	1.02B	969M
Unearned Revenue Non Current	15.04M	15.12M	13.81M	13.94M	16M
Pension & Other Post Retirement Benefits	6.72M	94.07M	100M	102M	99M
Deferred Tax Liability Non Current	634M	1.03B	989M	1.01B	861M
Other Non Current Liabilities	17.74M	20.82M	414M	23.65M	23M
Total Liabilities	11.09B	13.08B	13.47B	12.8B	12.11B
Common Stock, Total	120M	120M	120M	120M	120M
Additional Paid In Capital	911M	911M	911M	911M	911M
Retained Earnings	242M	257M	96.35M	206M	360M
Treasury Stock	-164M	-162M	-153M	-134M	-131M
Comprehensive Income and Other	4.99B	5B	4.85B	4.78B	4.01B
Total Common Equity	6.1B	6.13B	5.83B	5.88B	5.27B
Minority Interest	2.05B	2.33B	2.15B	2.72B	2.33B
Total Equity	8.15B	8.46B	7.97B	8.61B	7.6B
Total Liabilities And Equity	19.23B	21.53B	21.44B	21.41B	19.71B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	679M	678M	679M	680M	681M
ECS Total Common Shares Outstanding	679M	678M	679M	680M	681M
Book Value / Share	8.98	9.04	8.58	8.65	7.74
Tangible Book Value	-1.14B	-2.21B	-2.18B	-2.71B	-2.57B
Tangible Book Value Per Share	-1.67	-3.26	-3.21	-3.98	-3.77
Total Debt	9.33B	10.75B	10.65B	10.17B	9.64B
Net Debt	6.65B	10.17B	10B	9.16B	8.79B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	85.82M	100M	102M	99M
Debt Equivalent Oper. Leases	264M	312M	344M	377M	360M
Minority Interest, Total (Incl. Fin. Div)	2.05B	2.33B	2.15B	2.72B	2.33B
Equity Method Investments, Total	2B	1.96B	535M	69M	97M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	657M	1.06B	1.1B	956M	936M
Inventories - Work In Process, Total	721M	1.33B	1.21B	1.41B	1.41B
Inventories - Finished Goods, Total	881M	805M	1.14B	1.2B	1.05B
Land - (BS)	860M	1.16B	1.13B	1.23B	1.21B
Machinery, Total	2.53B	3.07B	3.18B	3.55B	3.45B
Full Time Employees	23.24K	26.33K	23.74K	23.83K	25.26K
Part Time Employees	-	-	-	-	-
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	24.01M	32.29M	31.58M	10.35M	23M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	183M	208M	59.32M	157M	402M
Depreciation & Amortization - CF	240M	284M	295M	304M	322M
Amortization of Goodwill and Intangible Assets - (CF)	50.16M	65.14M	80.15M	66.64M	62M
Depreciation & Amortization, Total	290M	349M	375M	371M	384M
Amortization of Deferred Charges, Total - (CF)	70.09M	58.52M	67.06M	67.04M	66M
(Gain) Loss From Sale Of Asset	1.2M	-1.73M	7.18M	1.38M	2M
Asset Writedown & Restructuring Costs	64.09M	69.98M	101M	73.26M	49M
(Income) Loss On Equity Investments - (CF)	-65.74M	-102M	-62.82M	-36.8M	8M
Other Operating Activities, Total	196M	15.95M	31.35M	247M	167M
Change In Accounts Receivable	-16.81M	-80.17M	-53.14M	-41.88M	-32M
Change In Inventories	-157M	-600M	-427M	25.82M	-97M
Change In Accounts Payable	40.45M	80.21M	103M	28.8M	94M
Change in Other Net Operating Assets	-7.08M	-9.01M	7.36M	9.64M	4M
Cash from Operations	597M	-10.87M	208M	902M	1.05B
Capital Expenditure	-247M	-266M	-210M	-233M	-265M
Sale of Property, Plant, and Equipment	639K	3.28M	5.43M	23.5M	4M
Cash Acquisitions	-519M	-1.53B	-29.47M	-286M	-108M
Divestitures	794M	91.37M	-	-	-
Sale (Purchase) of Intangible assets	-67.72M	-109M	-85.88M	-139M	-158M
Investment in Marketable and Equity Securities, Total	9.82M	-165M	-78.17M	1.52B	-52M
Cash from Investing	-29.39M	-1.98B	-398M	887M	-579M
Long-Term Debt Issued, Total	2.46B	1.13B	1.64B	4.01B	1.36B
Total Debt Issued	2.46B	1.13B	1.64B	4.01B	1.36B
Long-Term Debt Repaid, Total	-578M	-1.31B	-1.46B	-5.36B	-1.67B
Total Debt Repaid	-578M	-1.31B	-1.46B	-5.36B	-1.67B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-126M	-3.46M	-	-	-
Common Dividends Paid	-	-	-	-	-
Preferred Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-259M	-592K	-	-962K	-128M
Common & Preferred Stock Dividends Paid	-259M	-592K	-	-962K	-128M
Other Financing Activities, Total	-20.94M	7.93M	5.47M	-5.48M	-92M
Cash from Financing	1.47B	-173M	186M	-1.36B	-529M
Foreign Exchange Rate Adjustments	55.46M	35.55M	-15.09M	20.08M	-94M
Net Change in Cash	2.1B	-2.13B	-18.4M	450M	-155M
Supplemental Items
Cash Interest Paid	155M	350M	529M	571M	532M
Cash Income Tax Paid (Refund)	30.6M	196M	159M	176M	169M
Levered Free Cash Flow	64.88M	-925M	-1.26B	1.45B	1.03B
Unlevered Free Cash Flow	211M	-698M	-984M	1.83B	1.39B
Change In Net Working Capital	185M	1.16B	1.59B	-940M	-486M
Net Debt Issued / Repaid	1.88B	-177M	181M	-1.35B	-309M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.04	2.13	2.14	3.89	4.24
Return on Total Capital	2.26	2.37	2.43	4.42	4.84
Return On Equity %	3.57	3.44	2.2	2.64	6.17
Return on Common Equity	3.26	3.57	0.99	2.79	7.21
Margin Analysis
Gross Profit Margin %	39.78	36.8	37.84	39.48	38.8
SG&A Margin	21.52	19.63	20.73	16.16	15.22
EBITDA Margin %	15.92	15.89	15.65	22.3	22.56
EBITA Margin %	12.42	12.53	12.38	19.22	19.37
EBIT Margin %	11.4	11.46	11.16	18.3	18.54
Income From Continuing Operations Margin %	5.38	4.47	2.74	2.95	6.65
Net Income Margin %	3.71	3.43	0.9	2.18	5.34
Net Avail. For Common Margin %	3.71	3.43	0.9	2.18	5.34
Normalized Net Income Margin	2.77	2.61	0.52	4.5	5
Levered Free Cash Flow Margin	1.32	-15.25	-19.12	20.16	13.62
Unlevered Free Cash Flow Margin	4.28	-11.51	-14.92	25.38	18.41
Asset Turnover
Asset Turnover	0.29	0.3	0.31	0.34	0.37
Fixed Assets Turnover	1.55	1.61	1.58	1.7	1.8
Receivables Turnover (Average Receivables)	12.07	11.25	9.86	10.06	10.2
Inventory Turnover (Average Inventory)	1.39	1.4	1.23	1.24	1.34
Short Term Liquidity
Current Ratio	1.59	2.38	2.79	2.66	2.51
Quick Ratio	0.92	0.68	0.63	0.87	0.84
Operating Cash Flow to Current Liabilities	0.17	-0.01	0.09	0.42	0.52
Days Sales Outstanding (Average Receivables)	30.24	32.44	37.01	36.39	35.78
Days Outstanding Inventory (Average Inventory)	261.82	260.04	296.67	295.27	271.73
Average Days Payable Outstanding	69.58	52.02	64.74	69.01	71.18
Cash Conversion Cycle (Average Days)	222.48	240.46	268.93	262.66	236.32
Long Term Solvency
Total Debt/Equity	114.57	127.11	133.58	118.12	126.83
Total Debt / Total Capital	53.39	55.97	57.19	54.15	55.91
LT Debt/Equity	85.17	117.71	120.87	110.27	119.57
Long-Term Debt / Total Capital	39.69	51.83	51.75	50.55	52.71
Total Liabilities / Total Assets	57.64	60.72	62.82	59.79	61.43
EBIT / Interest Expense	2.41	1.92	1.66	2.19	2.42
EBITDA / Interest Expense	3.64	2.88	2.51	2.81	3.09
(EBITDA - Capex) / Interest Expense	2.59	2.14	2.04	2.42	2.63
Total Debt / EBITDA	10.95	10.3	9.59	6.01	5.42
Net Debt / EBITDA	7.8	9.74	9.01	5.42	4.94
Total Debt / (EBITDA - Capex)	15.43	13.83	11.82	6.97	6.37
Net Debt / (EBITDA - Capex)	10.99	13.08	11.1	6.29	5.81
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-7.62	22.92	8.71	9.41	4.33
Gross Profit, 1 Yr. Growth %	-12.97	13.7	11.79	11.69	2.53
EBITDA, 1 Yr. Growth %	-34.06	22.66	7.11	27.45	5.59
EBITA, 1 Yr. Growth %	-40.41	24.01	7.37	33.13	5.19
EBIT, 1 Yr. Growth %	-42.33	23.49	5.9	37.3	5.75
Earnings From Cont. Operations, 1 Yr. Growth %	-62.58	2.19	-33.37	30.02	134.74
Net Income, 1 Yr. Growth %	-70.45	10.36	-71.52	270.81	156.05
Normalized Net Income, 1 Yr. Growth %	-70.24	11.07	-79.79	103.21	16.14
Diluted EPS Before Extra, 1 Yr. Growth %	-70.2	10.64	-71.52	283.33	156.52
Accounts Receivable, 1 Yr. Growth %	13.28	48.3	7.61	7.01	-0.94
Inventory, 1 Yr. Growth %	12.84	41.69	8.06	2.23	-7.42
Net Property, Plant and Equip., 1 Yr. Growth %	11.33	24.69	0.57	2.81	-5.99
Total Assets, 1 Yr. Growth %	25.92	11.96	-0.43	1.97	-7.91
Tangible Book Value, 1 Yr. Growth %	-5.81	29.23	-1.18	2.56	-5.2
Common Equity, 1 Yr. Growth %	19.35	10.98	-4.94	9.6	-10.4
Cash From Operations, 1 Yr. Growth %	-46.23	-101.82	-2.02K	312.53	16.08
Capital Expenditures, 1 Yr. Growth %	-11.7	7.73	-21.37	3.61	13.73
Levered Free Cash Flow, 1 Yr. Growth %	-90.91	-1.6K	36.28	-186.69	-29.48
Unlevered Free Cash Flow, 1 Yr. Growth %	-75.26	-436.28	40.91	-235.1	-24.3
Dividend Per Share, 1 Yr. Growth %	-	-	-	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-1.64	6.56	15.6	9.06	6.84
Gross Profit, 2 Yr. CAGR %	-8.44	-0.53	12.74	13.42	8.43
EBITDA, 2 Yr. CAGR %	-25.75	-13.81	5.78	21.9	20.75
EBITA, 2 Yr. CAGR %	-26.12	-11.74	20.43	43.69	42.46
EBIT, 2 Yr. CAGR %	-29.21	-15.61	14.36	40.19	39.4
Earnings From Cont. Operations, 2 Yr. CAGR %	-36.04	-38.16	-17.48	-7.35	75.14
Net Income, 2 Yr. CAGR %	-45.92	-41.97	-43.94	-7.91	209.38
Normalized Net Income, 2 Yr. CAGR %	-48.3	-41.27	-52.01	50.24	597.02
Diluted EPS Before Extra, 2 Yr. CAGR %	-45.71	-41.65	-43.86	-7.7	213.58
Accounts Receivable, 2 Yr. CAGR %	8.35	29.62	26.33	7.28	2.93
Inventory, 2 Yr. CAGR %	-1.79	26.45	23.74	4.89	-2.71
Net Property, Plant and Equip., 2 Yr. CAGR %	8.05	17.82	11.98	0.3	-1.69
Total Assets, 2 Yr. CAGR %	11.24	18.73	5.58	0.41	-3.1
Tangible Book Value, 2 Yr. CAGR %	-20.26	35.32	13.01	0.35	-1.38
Common Equity, 2 Yr. CAGR %	12.44	9.54	2.71	2.06	-0.91
Cash From Operations, 2 Yr. CAGR %	2.43	-90.11	-40.93	2.41K	119.66
Capital Expenditures, 2 Yr. CAGR %	-10.73	-2.47	-7.96	-9.48	8.77
Levered Free Cash Flow, 2 Yr. CAGR %	318.61	13.82	352.8	182.56	-25.15
Unlevered Free Cash Flow, 2 Yr. CAGR %	2.97	-9.54	117.68	337.45	-4.14
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.21	5.95	7.27	13.5	7.46
Gross Profit, 3 Yr. CAGR %	-1.43	-1.59	3.42	13.21	9.66
EBITDA, 3 Yr. CAGR %	-13.72	-12.23	-7.33	20.36	16.18
EBITA, 3 Yr. CAGR %	-14.9	-12.2	-5.78	35.07	29.47
EBIT, 3 Yr. CAGR %	-17.29	-14.78	-8.97	32.87	27.61
Earnings From Cont. Operations, 3 Yr. CAGR %	-23.58	-25.23	-36.6	-7.09	26.35
Net Income, 3 Yr. CAGR %	-32.58	-30.68	-54.23	-5.97	29.52
Normalized Net Income, 3 Yr. CAGR %	-32.15	-32.34	-57.88	29.63	37.87
Diluted EPS Before Extra, 3 Yr. CAGR %	-32.45	-30.43	-54.06	-6	29.77
Accounts Receivable, 3 Yr. CAGR %	17.27	20.3	21.82	19.53	4.44
Inventory, 3 Yr. CAGR %	5.04	10.97	19.99	16.37	0.61
Net Property, Plant and Equip., 3 Yr. CAGR %	19.64	13.34	11.77	8.84	-1.84
Total Assets, 3 Yr. CAGR %	15.52	11.48	11.97	3.63	-2.44
Tangible Book Value, 3 Yr. CAGR %	-18.29	7.32	21.86	16.6	-1.52
Common Equity, 3 Yr. CAGR %	13	8.33	4.49	2.13	-2.28
Cash From Operations, 3 Yr. CAGR %	-6.8	-73.27	-42.76	14.76	801.93
Capital Expenditures, 3 Yr. CAGR %	2.16	-4.96	-9.23	-2.04	-2.26
Levered Free Cash Flow, 3 Yr. CAGR %	-21	529.77	20.87	187.08	77.86
Unlevered Free Cash Flow, 3 Yr. CAGR %	-11.36	51.94	4.86	106.6	143.72
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.02	7.03	8	7.18	7.1
Gross Profit, 5 Yr. CAGR %	0.52	0.73	4.01	3.99	5.3
EBITDA, 5 Yr. CAGR %	-7.2	-5.56	-3.34	2.45	5.53
EBITA, 5 Yr. CAGR %	-8.19	-6.57	-3.88	4.31	8.36
EBIT, 5 Yr. CAGR %	-9.75	-8.23	-5.84	3.29	7.42
Earnings From Cont. Operations, 5 Yr. CAGR %	-13.39	-16.33	-21.19	-19.98	-6.75
Net Income, 5 Yr. CAGR %	-19.64	-20.66	-36.98	-24.15	-8.26
Normalized Net Income, 5 Yr. CAGR %	-21.1	-20.17	-39.89	-8.68	-3.87
Diluted EPS Before Extra, 5 Yr. CAGR %	-19.6	-20.56	-36.87	-24.05	-8.1
Accounts Receivable, 5 Yr. CAGR %	0.97	17.6	20.82	14.93	13.88
Inventory, 5 Yr. CAGR %	6.58	14.46	12.16	8.73	10.48
Net Property, Plant and Equip., 5 Yr. CAGR %	13.06	18.82	16.52	8.52	6.18
Total Assets, 5 Yr. CAGR %	13.68	14.55	11.44	6.61	5.23
Tangible Book Value, 5 Yr. CAGR %	1.64	2.02	0.95	8.68	16.33
Common Equity, 5 Yr. CAGR %	10.38	11.05	6.64	4.06	0.63
Cash From Operations, 5 Yr. CAGR %	1.53	-58.1	-22.34	9.66	-1.17
Capital Expenditures, 5 Yr. CAGR %	-0.16	1.16	-2.01	-5.61	-1.11
Levered Free Cash Flow, 5 Yr. CAGR %	-4.52	10.99	57.12	230.24	7.51
Unlevered Free Cash Flow, 5 Yr. CAGR %	-1.25	-0.19	26.56	55.86	10.18
Dividend Per Share, 5 Yr. CAGR %	-	-	-	-	-